2095616-82-1

2095616-82-1 structure
2095616-82-1 structure

Name CH7057288
Synonyms 4-Pyridinecboxamide, 2-[2-[6,11-dihydro-6,6-dimethyl-8-[(methylsulfonyl)amino]-11-oxobenzo[b]naphtho[2,3-d]furan-3-yl]ethynyl]-N-(1,1-dimethylethyl)-6-methyl
CH7057288, 10 mM in DMSO
Inhibitor,Trk Rector,CH7057288,inhibit,Tropomyosin related kinase rector,CH 7057288,CH-7057288
Description CH7057288 is a potent and selective TRK inhibitor.
Related Catalog
Target

TRK

In Vitro CH7057288 induces regression of intracranial tumors and greatly improves event-free survival in an intracranial implantation model mimicking brain metastasis. CH7057288 can be a promising therapeutic agent for TRK fusion-positive cancer. TRK receptor tyrosine kinases are expressed as fusion proteins encoded by various fusion genes across a wide variety of cancer types, including lung and colorectal cancer[1].
References

[1]. Hiroshi Tanaka, et al. Abstract 4179: Potent and selective TRK inhibitor CH7057288. AACR Annual Meeting 2017; April 1-5, 2017.

Molecular Formula C32H31N3O5S
Molecular Weight 569.67
Storage condition 2-8℃
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.